|
|
|||
|
||||
OverviewFull Product DetailsAuthor: César Muñoz-Fontela (Bernhard Nocht Institute for Tropical Medicine, Germany) , Rafael Delgado (Hospital Universitario 12 de Octubre, Madrid, Spain)Publisher: Royal Society of Chemistry Imprint: Royal Society of Chemistry Volume: Volume 80 Weight: 0.606kg ISBN: 9781788015646ISBN 10: 1788015649 Pages: 308 Publication Date: 08 December 2021 Audience: College/higher education , Professional and scholarly , Tertiary & Higher Education , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsOverview of Antiviral Drug Discovery and Development: Viral Versus Host Targets; Advances in Prophylaxis and Therapy of Arenavirus Hemorrhagic Fevers; Vaccines and Antiviral Developments for SARS-CoV-2 in the Emergence of the COVID-19 Pandemic; Small-molecule and Synthetically Derived Antivirals for Ebola Virus and Other Filoviruses; Antiviral Strategies for Ebola Virus and Other Filoviruses: Antibodies; Vaccine Development in the Midst of Ebolavirus Disease Outbreaks; Remdesivir: Investigational Antiviral Drug with Activity Against Ebola and Other Emerging and Neglected Viruses; Therapeutics Against Nipah and Hendra Virus; Glycomimetics as Promising Inhibitors of Ebola Virus, Flavivirus and HIV Infections; Repurposing Approved Drugs to Block Highly Pathogenic Emerging Viruses; Receptors on Primary Phagocytes as Therapeutic Targets Against Highly Pathogenic Emerging VirusesReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |